• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088

Research Brief on Methyl 4-(difluoromethyl)benzoate (CAS: 444915-76-8): Recent Advances and Applications

Methyl 4-(difluoromethyl)benzoate (CAS: 444915-76-8) is a fluorinated aromatic ester that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications in drug discovery and development. This compound, characterized by the presence of a difluoromethyl group at the para position of the benzoate ring, serves as a versatile intermediate in the synthesis of bioactive molecules, particularly those targeting metabolic and inflammatory pathways. Recent studies have explored its utility in the design of enzyme inhibitors, prodrugs, and fluorinated analogs of known pharmaceuticals, highlighting its importance in modern medicinal chemistry.

One of the key areas of interest surrounding Methyl 4-(difluoromethyl)benzoate is its role in the development of fluorinated drug candidates. Fluorination is a common strategy in drug design to enhance metabolic stability, bioavailability, and binding affinity. The difluoromethyl group, in particular, is known to mimic the steric and electronic properties of hydroxyl or methyl groups while offering improved resistance to oxidative metabolism. Recent research has demonstrated the incorporation of this moiety into lead compounds for diseases such as cancer, diabetes, and neurodegenerative disorders, with promising preclinical results.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers utilized Methyl 4-(difluoromethyl)benzoate as a key intermediate in the synthesis of novel COX-2 inhibitors. The study reported that the difluoromethylated analogs exhibited superior selectivity and reduced gastrointestinal toxicity compared to their non-fluorinated counterparts. Another investigation, featured in Bioorganic & Medicinal Chemistry Letters, explored the compound's application in the development of fluorinated analogs of tyrosine kinase inhibitors, demonstrating enhanced potency against resistant cancer cell lines.

Beyond its pharmaceutical applications, Methyl 4-(difluoromethyl)benzoate has also been investigated for its utility in agrochemical research. A 2022 study highlighted its use as a precursor for the synthesis of herbicidal agents with improved environmental stability and efficacy. The difluoromethyl group's ability to modulate the physicochemical properties of these agents has opened new avenues for the design of next-generation agrochemicals.

Despite its promising applications, challenges remain in the large-scale synthesis and purification of Methyl 4-(difluoromethyl)benzoate. Recent advancements in catalytic fluorination methodologies, however, have addressed some of these limitations, offering more efficient and sustainable routes to its production. For instance, the use of transition metal catalysts and flow chemistry techniques has significantly improved yields and reduced the environmental impact of its synthesis.

In conclusion, Methyl 4-(difluoromethyl)benzoate (CAS: 444915-76-8) represents a valuable building block in the toolkit of medicinal and agrochemical chemists. Its unique structural features and demonstrated utility in diverse applications underscore its potential to drive innovation in drug and agrochemical development. Future research is expected to further explore its mechanistic roles and expand its applications, particularly in the context of targeted therapies and sustainable agriculture.

• 2967-66-0(Methyl 4-(trifluoromethyl)benzoate)
• 26107-80-2(Methyl 3,5-bis(trifluoromethyl)benzoate)
• 651735-47-6(Benzoic acid, 4-(trifluoromethyl)-, [4-(trifluoromethyl)phenyl]methyl ester)
• 96617-71-9(Ethyl 3,5-bis(trifluoromethyl)benzoate)
• 89540-39-6(Benzoic acid, 3-(fluoromethyl)-, methyl ester)
• 2557-13-3(Methyl 3-(trifluoromethyl)benzoate)
• 76783-59-0(Ethyl 3-(trifluoromethyl)benzoate)
• 64747-71-3(Benzoic acid, 4-(difluoromethyl)-, ethyl ester)
• 583-02-8(Ethyl 4-(trifluoromethyl)benzoate)
• 31083-14-4(Aceticacid, 2,2,2-trifluoro-, 4-ethylphenyl ester)